Risk of lymphoma in patients with RA treated with anti-TNFα agents

This publication has 17 references indexed in Scilit:

• Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
  Annals of the Rheumatic Diseases, 2005
• Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patients
  Arthritis & Rheumatism, 2004
• The use of TNF-α blocking agents in rheumatoid arthritis: an overview
  Expert Opinion on Pharmacotherapy, 2004
• Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
  Arthritis & Rheumatism, 2002
• Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies
  Published by Elsevier ,2002
• Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study
  BMJ, 1998
• Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.
  Annals of the Rheumatic Diseases, 1988
• Cancer morbidity in rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1984
• The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.
  Annals of the Rheumatic Diseases, 1983
• Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
  Journal of Chronic Diseases, 1978